YD Bio Ltd: director Chang Kochi exercised 3,135 shares

What happened

• Chang Kochi, director, was granted and became entitled to 3,135 restricted share units (RSUs) and the filing reports conversion/exercise activity for 3,135 shares on Sep 30, 2026. The grant is reported at $0.00 per share; the RSUs had an aggregate target grant date fair value of $60,000 (see footnote).

Key details

• Transaction date: Sep 30, 2026. Reported transaction codes: A (grant/award) for 3,135 RSUs at $0.00; M (exercise/conversion) for 3,135 shares (one entry showing price N/A, another showing $0.00 and disposition of 3,135 shares).
• Prices and values: $0.00 per share reported for the grant and conversion/disposition entries; aggregate target grant date fair value of the Granted RSUs was $60,000 on Mar 31, 2026 (footnote).
• Shares owned after the transaction: not reported in the filing.
• Relevant footnotes:
  • Each RSU represents a contingent right to receive one ordinary share (footnote F1).
  • The Granted RSUs were under the YD Bio Limited Equity Incentive Plan with an aggregate target grant date fair value of $60,000 and vest in four equal quarterly installments; the number vesting is determined by dividing $15,000 by the seven trading-day VWAP immediately prior to each vesting date (footnote F2).
  • The reporting person became entitled to a fixed number of RSUs on Sep 30, 2026 (Vesting Date) (footnote F3).
• Filing timeliness: the Form 4 was filed on Oct 6, 2026 for transactions dated Sep 30, 2026; the filing appears to be late.

Why it may matter

• The filing reports RSUs becoming vested/entitled and their conversion/exercise into shares; the same number of shares (3,135) are reported as disposed on the same date.
• This is a derivative-to-share conversion event (RSUs to ordinary shares) rather than a direct open-market purchase or gift.
• A filing does not show why the insider traded or why the company acted.